Overview
Location
United Kingdom
Mentions in press and media 6
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Feb 12, 2026 | Clinigen Announces World-First Pharmaceutical Approval for Prolacta Bioscience's PreemieFort® Enteral Solution, Human Milk-Based Product in Japan | Clinigen obtained approval for Prolacta's "PreemieFort® Enteral Solution", a human milk-based fortifier, as an approved pharmaceutical product in Japan indicated for the "Nutritional management of neonates and infants present... |
| Nov 29, 2021 | Nippon Shinyaku : Implements VILTEPSO Managed Access Program | NEWS RELEASE November 29, 2021 Nippon Shinyaku Implements VILTEPSO® Managed Access Program Kyoto, Japan, November 29, 2021 - Nippon Shinyaku Co., Ltd. (Nippon Shinyaku; Headquarters: Kyoto; President: Toru Nakai)... |
| Sep 2, 2021 | PRESS RELEASE : PAION SIGNS EXCLUSIVE UK SUPPLY AND DISTRIBUTION AGREEMENT WITH CLINIGEN | DGAP-News: PAION AG / Key word(s): Miscellaneous PAION SIGNS EXCLUSIVE UK SUPPLY AND DISTRIBUTION AGREEMENT WITH CLINIGEN 2021-09-02 / 14:00 The issuer is solely responsible for the content of this announcement. ----------------------------... |
| Apr 8, 2021 | CLINIGEN GROUP PLC Clinigen : launches Managed Access Program with BeiGene for zanubrutinib | [email protected]. 8 April 2021 Clinigen launches Managed Access Program with BeiGene for zanubrutinib Clinigen Group plc (AIM: CLIN, 'Clinigen'), the global pharmaceutical Products and Services company, has launched a Manage... |
| Apr 6, 2021 | CLINIGEN GROUP PLC Clinigen : to begin supplying Erwinase® in the UK | 6 April 2021 Clinigen to begin supplying Erwinase® in the UK Clinigen Group plc (AIM: CLIN, 'Clinigen'), the global pharmaceutical Products and Services company, today announces that it will be providing access to Erwinase® (L-asparaginaseE... |
Reviews 0
FAQ about Clinigen
What has the press written about Clinigen?
Parsers VC has collected 6 articles mentioning Clinigen, among them “Clinigen Announces World-First Pharmaceutical Approval for Prolacta Bioscience's PreemieFort® Enteral Solution, Human Milk-Based Product in Japan” (Feb 12, 2026) and “Nippon Shinyaku : Implements VILTEPSO Managed Access Program” (Nov 29, 2021).
Is Clinigen still active?
Yes, Clinigen is active; its latest activity on Parsers VC dates from Feb 19, 2026.